1. Pallansch, M. Epidemiology of group B Coxsackieviruses. in Coxsackieviruses — A General Update (eds Bendinelli, M. & Friedman, H.) 399–417 (Plenum, New York, 1988).
2. Kaplan, M.H., Klein, S.W., McPhee, J. & Harper, R.G. Group B Coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. infect. Dis. 5, 1019–1032 (1983).
3. Ge, K.Y. et al. The protective effect of selenium against viral myocarditis in mice. in Selenium in Biology and Medicine – Part B (eds Combs, G.F., Spallholz, J.E., Levander, O.A. & Oldfield, J.E.), 761–768 (Van Nostrand/Reinhold, New York, 1987).
4. Beck, M.A. et al. Benign human enterovirus bcomes virulent in selenium-deficient mice. J. med. Virol. 43, 166–170 (1994).
5. Beck, M.A., Shi, Q., Morris, V.C. & Levander, O.A. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med. l, xxx–xxx (1995).